Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome [7]

Intensive Care Medicine

Volumn 27, Issue 6, 2001, Pages 1103-1104

  Jounieaux, V ^a   Leleu, O ^a   Mayeux, I ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; METHYLENE BLUE; NITRIC OXIDE;

ADULT; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; BLOOD GAS ANALYSIS; CASE REPORT; CLUBBING FINGERS; CYANOSIS; HEPATOMEGALY; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; LETTER; LUNG ARTERIOVENOUS SHUNT; LUNG ARTERY PRESSURE; MALE; PROTHROMBIN TIME; RESPIRATORY FAILURE;

FATAL OUTCOME; HEMODYNAMIC PROCESSES; HEPATOPULMONARY SYNDROME; HUMANS; MALE; METHYLENE BLUE; MIDDLE AGED; NITRIC OXIDE; VASODILATOR AGENTS;

EID: 0034923028     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340100967     Document Type: Letter

References (5)

1. Methylene blue in the hepatopulmonary syndrome
2. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis
3. Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis
4. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation
5. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome